SLP: Simulations Plus Corp Price-to-Revenue Coefficient

Corporate company logo of Simulations Plus Inc. (SLP)

Simulations Plus, Inc. (SLP) is a global leader in biomodeling whose GastroPlus software is recognized as the FDA benchmark for reducing R&D costs. This price-to-sales chart from the GURU.Markets terminal is supported by AI implementation and new regulatory requirements, while 4.60 reflects the latest value of the metric. The final constraining factors remain prolonged deal cycles and budget optimization by pharmaceutical behemoths.

SLP Simulations Plus Inc Price-to-Revenue Ratio (07/04/2022 - 10/18/2026)

Simulations Plus Corp (SLP) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price simulations-plus.com|SLP - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Simulations Plus Corp|SLP - Total Company Value
- company book value details:
Net Asset Value per Share Simulations Plus|SLP - Company Book Value|Capitalization to Book Value Ratio simulations-plus.com|SLP - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Simulations Plus, Inc.|SLP - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Simulations Plus Inc.|SLP - Company Debts|Debts to Book Capitalization Ratio Simulations Plus Corp|SLP - Company Long-Term Debt|Company Short-Term Debt Simulations Plus|Quick Ratio simulations-plus.com
- earnings and multiples data:
SLP - Company Net Income|Company Profit Forecast Simulations Plus, Inc.|SLP - Price to Earnings Ratio|Future Price to Earnings Multiple Simulations Plus Inc|SLP - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Simulations Plus Corp|SLP - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Simulations Plus|SLP - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months simulations-plus.com|SLP - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Simulations Plus, Inc.
- total revenue and sales volume data:
SLP - Company Revenue|Company Future Sales simulations-plus.com|SLP - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Simulations Plus Corp
Fundamental company analysis:simulations-plus.com - SLP
Core merchandise of Simulations Plus Inc.

For the high-margin software business of Simulations Plus, Inc. (SLP) with its pristine balance sheet, the P/S ratio serves as the key metric for the market value of each unit of revenue generated. By analyzing the price-to-sales ratio on the GURU.Markets platform, an investor assesses the relationship between market capitalization and sales volume, which allows them to determine the extent of the premium paid for the company's technological leadership in biosimulations and avoid purchasing the asset at a local peak.

Competitors of Simulations Plus, Inc.

Market Cap to Sales Volume VEEV|P/S Multiple DOCS (Doximity)|Price-to-Revenue Coefficient HealthEquity Inc (HQY)|WAY - Price-to-Revenue Ratio|Price to Sales CorVel Corp.|Privia Health Group (PRVA) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio HURN|Price-to-Revenue Ratio Certara|Omnicell Inc (OMCL) - Price-to-Revenue Coefficient|Market Cap to Revenue GDRX (GoodRx Corp)|SDGR (Schrodinger Corp) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Phreesia, Inc. PHR|OMDA (omadahealth.com) - Price-to-Sales Ratio|EVH - Price-to-Revenue Ratio|HSTM: Price-to-Revenue Ratio|DH (Definitive Healthcare Inc.) - Market Cap to Revenue|Consensus Corp (CCSI) - P/S Multiple|Price-to-Revenue Ratio Agilon Health|absci.com (ABSI) - Price-to-Revenue Coefficient|Market Cap to Revenue SY (So-Young International Inc.)|NRC (NRC Health) - Market Capitalization-to-Revenue Ratio|P/S Multiple SPOK (Spok Corp)|Price-to-Revenue Coefficient OptimizeRx Inc. (OPRX)|TBRG - Price-to-Revenue Ratio|SOPH (SOPHiA GENETICS SA) - Market Cap to Revenue Ratio|HCAT: P/S Multiple|Market Cap to Revenue CareCloud|Market Cap to Revenue RSSS|DLH Holdings Corp (DLHC) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio OneMedNet Corporation (ONMD)|Price-to-Revenue Coefficient scienture.com|Price-to-Revenue Ratio Healthcare Triangle, Inc. HCTI|iSpecimen Inc - Price-to-Revenue Ratio|BFRG - Price-to-Revenue Ratio|Price-to-Sales Ratio WORX|MSPR: P/S Multiple|ICCT - Price-to-Revenue Coefficient|Market Cap to Revenue MEDS|ORGS (Orgenesis Inc) - Market Cap to Sales Volume|Market Cap to Revenue RCM (R1 RCM Inc.)|SHCR (Sharecare Inc) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Streamline Health Solutions STRM|SYRA - Market Cap to Revenue|ApolloMed - P/S Multiple|Price to Sales Model N Inc|NXGN: P/S Multiple